Industry-Sponsored Research Week
University-Industry Engagement Advisor

Wistar Institute in research collaboration with Harbour BioMed to discover novel antibody therapies for cancer and infectious diseases

By David Schwartz
Published: June 12th, 2018

The Wistar Institute and Harbour BioMed have signed a multi-year, multifaceted research collaboration to co-discover novel antibodies for the treatment of cancer and infectious diseases. 

The collaboration will combine Wistar’s fundamental research expertise in cancer biology and immunology with Harbour BioMed’s H2L2 platform for generating fully human monoclonal antibodies directed against unique targets. Wistar and Harbour BioMed will work together to select targets, then generate and validate novel antibodies against tumor and infectious antigens, with a goal of generating commercially viable therapeutic candidates.

“This partnership embodies Wistar’s philosophy of establishing collaborations that operate in the early stages of the discovery process, in order to accelerate the advancement of the high-risk, high-reward preclinical drug discoveries,” said Heather Steinman, PhD, MBA, vice president for business development and executive director of technology transfer at Wistar. 

The agreement will support numerous antibody discovery programs per year, overseen by a joint steering committee. David B. Weiner, PhD, executive vice president and director of the Vaccine & Immunotherapy Center at Wistar, will be playing a leading role in overseeing Wistar’s scientific efforts in the collaboration.

“Combining Harbour BioMed’s next generation human antibody platform technology with Wistar’s core strengths in early stage research and discovery is an innovative industry-academia collaboration specifically designed to rapidly move attractive therapeutic candidates into the next phase of clinical development,” said Mai-Jing Liao, PhD, MBA, senior VP for business development and portfolio management at Harbour BioMed. 

Source: The Wistar Institute

Posted under: University-Industry Engagement Week

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment